Divalproex Sodium Tablet, Extended Release
Product Images NDC 68788-4100

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-4100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium Er Tab 500mg (Container)

This text contains information about the medication Divalproex Sodium ER Tablet 500mg. It includes details such as the generic name, ingredients, manufacturer, appearance, storage instructions, and a caution regarding the transfer of the drug. The text also mentions the prohibition of transferring the medication to anyone other than the prescribed patient due to federal law.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This text provides information on the percentage reduction in CPS rate by comparing high dose and low dose Divalproex Sodium Delayed-Release Tablets in patients. The formula for improvement is given and it shows a comparison between the two doses. It also mentions that 50% of patients were involved in the study.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.